Opportunity for pharmacists in telehealth, team-based care: Clinical inertia

Abstract

Introduction: A variety of team-based telehealth interventions have recently been developed and piloted in a number of practice settings. Despite the variety of intervention designs, clinical inertia (CI) continues to be problematic for therapeutic intensification and subsequent disease control. Commentary: Based on recent literature, pharmacists have the ability to mitigate a number of factors contributing to CI. Considering CI continues to limit overall effectiveness of team-based telehealth interventions, involving pharmacists more intentionally in these interventions would provide benefit to therapeutic intensification and therapeutic outcomes.